MONROVIA, CA, November 19, 2008
/24-7PressRelease/ -- GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida.
The conference will take attendees through "The Life Cycle of a Cancer Biomarker"; examining the path from the identification of a candidate biomarker, development through validation, onto the clinic to be able to identify unmet needs and spark new discoveries back in the laboratory. This unique organization of the sessions will allow attendees to view the interdependency of the entire process. Sessions include: The Birth of a Biomarker - Pre-clinical, Growing pains - Early Clinical Design, Adolescence - Clinical Validation, Maturity - In the Clinic, and Going Full circle - Lessons Learned from the Clinic.
The conference features prominent leaders from all across the field of cancer research to cover new and innovative techniques for biomarker detection and validation.
Keynote and featured presentations will be given by Dr. Samir Hanash, Program Head of the Fred Hutchinson Cancer Research Center, Dr. Christopher Foster, Professor, University of Liverpool, and Dr. Garret Hampton, Executive Director of Molecular and Medical Sciences at Celgene San Diego. Other speakers from NIH, FDA, Merck, Abbott laboratories, Amgen, Roche, MD Anderson Cancer Center and more, will present on the 19th and 20th.
For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=142
ABOUT GTCbio
GTCbio organizes scientific conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO 434 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 256-6460 email: infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- De Yang from the National Cancer Institute to Speak at the 7th Cytokines & Inflammation Conference
- Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners to Give Featured Presentation at 5th Stem Cell Research & Therapeutics Conference
- Charles Peterfy, Chief Scientific Officer at Synarc to Give Featured Presentation at GTCbio's 4th Imaging in Preclinical & Clinical Drug Development Conference
- Michael Karin, Professor at UCSD to Give Keynote Speech at 7th Cytokines & Inflammation Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough to Give Joint Featured Presentation at GTCbio's CNS Diseases Partnering & Deal-Making Summit on Dec. 1-2, 2008 in Boston, MA
- GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
Other Press Release Headlines:
